JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asp, M. L.
Right arrow Articles by Wolf, B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asp, M. L.
Right arrow Articles by Wolf, B. W.
Journal of the American College of Nutrition, Vol. 25, No. 1, 49-55 (2006)
Published by the American College of Nutrition

Gamma-Cyclodextrin Lowers Postprandial Glycemia and Insulinemia without Carbohydrate Malabsorption in Healthy Adults

Michelle L. Asp, MS, RD, LD, Steven R. Hertzler, PhD, RD, JoMay Chow, PhD and Bryan W. Wolf, PhD

Medical Dietetics Division, School of Allied Medical Professions, College of Medicine and Public Health (M.L.A.)
Department of Human Nutrition, College of Human Ecology (S.R.H.)
The Ohio State University, Ross Products Division, Abbott Laboratories (J.C., B.W.W.) Columbus, Ohio

Address reprint requests to: Steven R. Hertzler, PhD, RD, LD, Assistant Professor, Department of Human Nutrition, College of Human Ecology, The Ohio State University, 325 Campbell Hall, 1787 Neil Avenue, Columbus, OH 43210-1295. E-mail: hertzler.4{at}osu.edu

Objective: Preliminary in vitro and animal studies have shown that gamma-cyclodextrin (GCD) is a slowly and completely digestible carbohydrate. The objective of this study was to determine the glycemic and insulinemic responses to GCD in humans. Breath hydrogen excretion was measured simultaneously to evaluate carbohydrate malabsorption.

Methods: Healthy adult subjects (N = 32) received 50 g of carbohydrate from GCD or a rapidly digested maltodextrin (MD) in a double-masked, randomized, crossover design. Plasma glucose (fingerstick) and serum insulin (venous) concentrations were measured at baseline and at 15, 30, 45, 60, 90, 120, 150, and 180 min postprandially. Breath hydrogen excretion was monitored hourly for 8 h postprandially. The severity of gastrointestinal symptoms (nausea, cramping, distension, flatulence) was rated by the subjects on a ranked scale for two 24-h periods postprandially.

Results: The mean baseline-adjusted peak plasma glucose concentration was 47% lower (P < 0.001), and the mean baseline-adjusted peak serum insulin concentration was decreased by 45% (P < 0.001) after subjects consumed GCD compared with MD. Positive incremental area under the curve (0–120 min) was reduced 45% for plasma glucose and 49% for serum insulin by GCD compared with MD (P < 0.001 in each case). There were no differences between GCD and MD in the proportion of positive breath hydrogen tests and both carbohydrates were equally well tolerated.

Conclusions: GCD effectively lowers postprandial glycemia and insulinemia compared with MD, without resulting in appreciable carbohydrate malabsorption or gastrointestinal intolerance.

Key words: gamma-cyclodextrin, glycemia, insulinemia, breath hydrogen






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Nutrition.